CAS: 3161-05-5

6,7-Dimethoxy-1-(pyridin-4-yl)-1,2,3,4-tetrahydroisoquinoline is a molecule that binds to the estrogen receptor. It has been shown to have an inhibitory effect on the development of autoimmune diseases and cancer in animal models. 6,7-Dimethoxy-1-(pyridin-4-yl)-1,2,3,4-tetrahydroisoquinoline has also been shown to be a potential treatment for inflammatory diseases. This drug has an ethynyl group that can be metabolized into a nitro group by oxidation. Molecular modelling studies have shown that 6,7-dimethoxy-1-(pyridin-4-yl)-1,2,3,4 tetrahydroisoquinoline is capable of binding to the ERβ receptor with high affinity and selectivity.